Prognostic factors in patients with metastatic urothelial carcinoma who have been treated with atezolizumab

Tural, D.Olmez, O. F.Sumbul, A. T.Ozhan, N.Akar, E.Cakar, B.Kostek, O.2024-02-232024-02-2320200923-75341569-8041https://doi.org/10.1016/j.annonc.2020.08.853https://hdl.handle.net/20.500.12452/11577ESMO Virtual Congress -- SEP 19-OCT 18, 2020 -- ELECTR NETWORK[Abstract Not Availabe]eninfo:eu-repo/semantics/openAccess[Keyword Not Available]Prognostic factors in patients with metastatic urothelial carcinoma who have been treated with atezolizumabConference Object31S598S598Q1WOS:000573469101069Q110.1016/j.annonc.2020.08.853